The mushroom cultivator will be supplying a private client for clinical research purposes The post Optimi Health enters $1.2M psilocybin distribution...
The first three months of 2023 have been a whirlwind for the psychedelic industry– to say the least. Though it has been a particularly difficult quarter,...
Psychedelic investors in Lucy Scientific Discovery (Nasdaq: LSDI) may be unaware of the close ties the company has with beleaguered cannabis publisher...
A comprehensive overview of psilocybin legal status, around the world. The post A comprehensive overview of psilocybin legality appeared first on Psil...
BOSS is not only concerned with cannabis; the company has taken a step into the field of psychedelics with its majority acquisition of NeonMind. The brand...
Over 100 days after they first contacted the Health Minister of Canada--The Honourable Patty Hadju--four terminal cancer patients have been granted permission...
In just over 100 days, four Canadians approved for end-of-life psilocybin therapy: the first exemption for legal use of “magic mushrooms” since they...
Enveric Biosciences is working with the University of Calgary’s Hotchkiss Brain Institute in Calgary to establish a groundbreaking clinical trial for...
Lophos Pharma is a Canadian peyote-focused psychedelics company. It was co-founded by wife and husband duo Claire and Evan Stawnyczy to explore mescaline’s...
A lot is going on in the world of psychedelic drug research. Truffle Report has put together this roundup the top corporate and scientific developments...